Cite

HARVARD Citation

    Rosén, K. et al. (n.d.). Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'. British journal of dermatology. pp. 15-16. [Online]. 
  
Back to record